Work

A Phase 1b, open-label study to evaluate the safety and tolerability of the putative remyelinating agent, liothyronine, in individuals with multiple sclerosis (S56.003)

Year: 2019

Type: article

Source: Neurology

DOI: 10.1212/wnl.92.15_supplement.s56.003

Authors: Scott Newsome, Thomas Shoemaker, Fan Tian, Kate Fitzgerald, Pavan Bhargava, Sarah Snoops, David Cooper, Jennifer Mammen, Ellen Mowry, Peter Calabresi

Institutions: Johns Hopkins Hospital, Rush University Medical Center, Johns Hopkins University, Johns Hopkins Bayview Medical Center

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3202223588

FWCI:

Cites:

Cited by:

Related to: 10